Gemzar (GEM-zar, gemcitabine), the first new drug for advanced pancreatic cancer in 30 years

Lilly is now marketing Gemzar (GEM-zar, gemcitabine), the first new drug for advanced pancreatic cancer in 30 years.

It's an alternative to the usual therapy with 5-fluorouracil.

Gemzar seems to help improve survival and reduce pain.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote